Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.
Tada A, Minami T, Kitai H, Higashiguchi Y, Tokuda M, Higashiyama T, Negi Y, Horio D, Nakajima Y, Otsuki T, Mikami K, Takahashi R, Nakamura A, Kitajima K, Ohmuraya M, Kuribayashi K, Kijima T. Tada A, et al. Among authors: takahashi r. Lung Cancer. 2023 Jun;180:107219. doi: 10.1016/j.lungcan.2023.107219. Epub 2023 Apr 26. Lung Cancer. 2023. PMID: 37146474 Free article.
Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma.
Horio D, Minami T, Kitai H, Ishigaki H, Higashiguchi Y, Kondo N, Hirota S, Kitajima K, Nakajima Y, Koda Y, Fujimoto E, Negi Y, Niki M, Kanemura S, Shibata E, Mikami K, Takahashi R, Yokoi T, Kuribayashi K, Kijima T. Horio D, et al. Among authors: takahashi r. Cancer Sci. 2020 Aug;111(8):2895-2906. doi: 10.1111/cas.14523. Epub 2020 Jul 6. Cancer Sci. 2020. PMID: 32530527 Free PMC article.
EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest.
Ishigaki H, Minami T, Morimura O, Kitai H, Horio D, Koda Y, Fujimoto E, Negi Y, Nakajima Y, Niki M, Kanemura S, Shibata E, Mikami K, Takahashi R, Yokoi T, Kuribayashi K, Kijima T. Ishigaki H, et al. Among authors: takahashi r. Biochem Biophys Res Commun. 2019 Nov 19;519(4):846-853. doi: 10.1016/j.bbrc.2019.09.076. Epub 2019 Sep 24. Biochem Biophys Res Commun. 2019. PMID: 31558317
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status.
Minami S, Kijima T, Hamaguchi M, Nakatani T, Koba T, Takahashi R, Takeuchi Y, Kida H, Nagatomo I, Yamamoto S, Tachibana I, Komuta K, Kawase I. Minami S, et al. Among authors: takahashi r. Lung Cancer. 2013 Nov;82(2):271-5. doi: 10.1016/j.lungcan.2013.07.022. Epub 2013 Aug 6. Lung Cancer. 2013. PMID: 23993733 Clinical Trial.
A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment.
Nishino K, Imamura F, Morita S, Mori M, Komuta K, Kijima T, Namba Y, Kumagai T, Yamamoto S, Tachibana I, Nakazawa Y, Uchida J, Minami S, Takahashi R, Yano Y, Okuyama T, Kumanogoh A. Nishino K, et al. Among authors: takahashi r. Lung Cancer. 2013 Nov;82(2):299-304. doi: 10.1016/j.lungcan.2013.08.009. Epub 2013 Aug 21. Lung Cancer. 2013. PMID: 24018023
Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangement in congenital pulmonary airway malformation.
Tetsumoto S, Kijima T, Morii E, Goya S, Minami T, Hirata H, Takahashi R, Kohmo S, Inoue K, Nagatomo I, Takeda Y, Kida H, Tachibana I, Kumanogoh A. Tetsumoto S, et al. Among authors: takahashi r. Clin Lung Cancer. 2013 Jul;14(4):457-60. doi: 10.1016/j.cllc.2012.12.005. Epub 2013 Jan 26. Clin Lung Cancer. 2013. PMID: 23357247 No abstract available.
3,100 results